There are 3164 resources available
Personalised immunotherapy approach and future
Presenter: Christian Blank
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
ESMO-MCBS coming of age: can we extend beyond registration studies?
Presenter: Sjoukje Oosting
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
Invited Discussant 799MO, 800MO and 801MO
Presenter: Sara Garrido Paniagua
Session: Mini oral session 1: Haematological malignancies
Resources:
Slides
Webcast
Combinations with IO
Presenter: Jarushka Naidoo
Session: Treating KRAS-mutated NSCLC
Resources:
Slides
Webcast
Optimal sequencing of therapeutic strategies in biomarker unselected MSS CRC
Presenter: Chiara Cremolini
Session: Metastatic colorectal cancer: Changing paradigms and the relevance for patient care
Resources:
Slides
Webcast
How to manage safety
Presenter: Ilaria Colombo
Session: Antibody drug conjugates (ADCs): Are there new therapeutic approaches in gynaecological cancers?
Resources:
Slides
Webcast
Invited Discussant LBA73, LBA74 and LBA75
Presenter: Manuela Schmidinger
Session: Proffered paper session 1: GU tumours, non-prostate
Resources:
Slides
Webcast
Noncoding regions as a source of targetable tumour-specific antigens
Presenter: Sebastian Amigorena
Session: Beyond coding neoantigens: What else is there for T cells to see?
Resources:
Slides
Webcast
Incorporating ctDNA into RECIST v1.1: Steps ahead
Presenter: Elena Garralda
Session: New endpoints in early clinical trials
Resources:
Slides
Webcast
Invited Discussant 440O, 441O and 442O
Presenter: Emeline Tabouret
Session: Proffered paper session: CNS tumours
Resources:
Slides
Webcast